[Retracted] A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma

Figure 2

FKBP10 expression in tissues and cell lines of patient with clear cell renal cell carcinoma, FKBP10 expression in tissues was checked through qRT-PCR (a) and western blot (b), vs. normal. QRT-PCR was utilized to determine FKBP10 expression in tumors with different sizes (c), vs. ≤4 group; staging (d), vs. stage III + IV; degree of differentiation (e), vs. well-differentiated; and in different cells (f), vs. HK-2 cell.

(a)

(b)

(c)

(d)

(e)

(f)